TrialHuman vaccines & immunotherapeutics2017

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial.

Bhagirath B Solanki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.